1. Motola-Kuba D，Zamora-Valdes D，Uribe M，et al. Hepatocellular carcinoma. An overview. Ann Hepatol 2006；5：16-24.

2. Pawlotsky JM.Therapy of hepatitis C：from empiricism to eradication. Hepatology 2006；43：S207-220.

3. Pekow JR，Bhan AK，Zheng H，et al. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer 2007；109：2490-2496.

4. Kim KH，Hong SP，Kim K，et al. HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma. Biochem Biophys Res Commun 2007；355：883-888.

5. Conjeevaram HS，Kleiner DE，Everhart JE，et al. Race，insulin resistance and hepatic steatosis in chronic hepatitis C. Hepatology 2007；45：80-87.

6. Hara Y，Hino K，Okuda M，et al. Hepatitis C virus core protein inhibits deoxycholic acid-mediated apoptosis despite generating mitochondrial reactive oxygen species. J Gastroenterol 2006；41：257-268.

7. Vallet S，Gouriou S，Nkontchou G，et al. Is hepatitis C virus NS3 protease quasispecies heterogeneity predictive of progression from cirrhosis to hepatocellular carcinoma？ J Viral Hepat 2007；14：96-106.

8. Hassan M，Selimovic D，Ghozlan H，et al. Induction of high- molecular weight （HMW） tumor necrosis factor （TNF） alpha by hepatitis C virus （HCV） non-structural protein 3 （NS3） in liver cells is AP-1 and NF-kappa B-dependent activation. Cell Signal 2007；19：301-311.

9. Bouchard M J，Navas-Martin S. Hepatitis B and C virus hepatocarcinogenesis：lessons learned and future challenges［J］. Cancer letters，2011，305（2）：123-143.

10. Imai K，Takai K，Nishigaki Y，et al. Insulin resistance raises the risk for recurrence of stage I hepatocellular carcinoma after curative radiofrequency ablation in hepatitis C virus-positive patients：A prospective，case series study［J］. Hepatology Research，2010，40（4）：376-382.

11. 董菁，江家骥.病毒相关性肝细胞癌抗病毒治疗的临床意义［J］.中华肝脏病杂志，2013，21（005）：332-334.

12. Toyoda H，Kumada T，Kaneoka Y，et al. Amino acid substitutions in the hepatitis C virus core region are associated with postoperative recurrence and survival of patients with HCV genotype 1b-associated hepatocellular carcinoma［J］. Annals of surgery，2011，254（2）：326-332.